Loading clinical trials...
Loading clinical trials...
EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL)
Conditions
Locations
73
Argentina
Hospital Britanico de Buenos Aires /ID# 274419
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Hospital Universitario Austral /ID# 274393
Pilar, Buenos Aires, Argentina
Instituto Alexander Fleming /ID# 277284
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
Hospital Privado Universitario De Córdoba /ID# 274457
Córdoba, Córdoba Province, Argentina
Hospital Italiano de Buenos Aires /ID# 274418
Buenos Aires, Argentina
Fundacion Argentina contra la Leucemia (FUNDALEU) /ID# 274390
Buenos Aires, Argentina
Start Date
March 28, 2025
Primary Completion Date
September 1, 2031
Completion Date
September 1, 2031
Last Updated
February 17, 2026
NCT07545603
NCT06337318
NCT05139017
NCT05006716
NCT06026319
NCT06510361
Lead Sponsor
AbbVie
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions